A Prospective Clinical Study Observed the Effects of Tubeless Anesthesia Method That Preserves Spontaneous Breathing and the Double-lumen Bronchial Intubation on the Brain Health During the Perioperative Period
Tubeless Anesthesia With Preserved Spontaneous Breathing and the Construction of a Perioperative Brain Health Safety System for Thoracic Surgery Patients Study 2: A Prospective Clinical Study Observing the Impact of Two Anesthesia Techniques-Tubeless With Preserved Spontaneous Breathing Versus Double-Lumen Endotracheal Intubation-on Perioperative Brain Health
2 other identifiers
observational
400
1 country
1
Brief Summary
This project conducts a prospective cohort study. By using multiple questionnaire survey methods such as the Pittsburgh Sleep Quality Index (PSQI) electronic wristband, QOR15, Pain Catastrophizing Scale (PCS), European Five-Dimensional Health Scale (EQ-5D), Revised American Pain Society Patient Follow-up Questionnaire (APS-POQ-R), Mini-Mental State Examination (MMSE), as well as perioperative stress and related indicators, hypothalamic-pituitary-adrenal axis (HPA) endocrine indicators, sublingual microcirculation, electroencephalogram, etc., comprehensive assessment is made of the correlations between the two different anesthesia methods of Tubeless retention of spontaneous breathing and double-lumen bronchial intubation and postoperative sleep, chronic pain and cognitive function, to construct a perioperative brain health safety system to improve prognosis; at the same time, optimize the perioperative sedation and analgesia plan and promote the postoperative brain health recovery of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2026
CompletedStudy Start
First participant enrolled
July 20, 2026
CompletedFirst Posted
Study publicly available on registry
July 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
July 22, 2026
July 1, 2026
1.4 years
July 13, 2026
July 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Concentration of cognitive function biomarkers in the serum samples of 400 patients
At time points T1, T2, and T3, 5 ml of peripheral venous blood was collected to test the biological indicators of postoperative cognitive function.
Before the start of the surgery (T1), at the end of the surgery (T2), and on the first day after the surgery (T3)
Concentrations of HPA axis-related indicators in the serum samples of 400 patients
At the TI-T2 time point, 5 ml of peripheral venous blood was collected for the detection of HPA axis-related indicators.
Before the start of the surgery (T1), at the end of the surgery (T2)
The concentrations of laboratory test indicators in the serum samples of 400 patients
Record the laboratory test indicators at time points T1 and T3
Before the start of the surgery (T1), and on the first day after the surgery (T3)
Secondary Outcomes (7)
Anesthesia Record Form
at the end of the surgery (T2)
Case information system collection
Before the start of the surgery (T1), and on the first day after the surgery (T3)
Anesthesia Record Form
During the operation
Postoperative follow-up records
through study completion, an average of 1 year
Postoperative follow-up records
through study completion, an average of 1 year
- +2 more secondary outcomes
Other Outcomes (1)
Postoperative follow-up records
through study completion, an average of 1 year
Study Arms (2)
tubeless group
Patients undergoing elective non-anatomic partial lung resection surgery using the Tubeless technique for maintaining spontaneous breathing anesthesia
double-lumen bronchial intubation group
Patients undergoing elective non-anatomic lung segmentectomy surgery using the double-lumen bronchial tube anesthesia method
Eligibility Criteria
Patients who underwent elective non-anatomic partial lung resection surgery at the First Affiliated Hospital of Guangzhou Medical University
You may qualify if:
- Patient age: 18 - 75 years old
- Patients meeting the standards of the American Society of Anesthesiologists (ASA) I-III grade and the New York Heart Association (NYHA) I-II class
- Body Mass Index (BMI) \< 30 kg/m2
- Intraoperative blood loss less than 300 ml
- No severe cardiac or pulmonary dysfunction \[first-second forced vital capacity (FEV1%) predicted value\] \> 50%, ejection fraction (EF) \> 50%
- No contraindications related to paravertebral nerve block and intercostal nerve block
- Able to sign the informed consent form and possess communication, reading and writing abilities
- Postoperative hospital stay of at least one day
- No preoperative sleep disorders, no cognitive dysfunction (PSQI ≤ 10 points, PCS ≤ 38 points, MMSE \> 27 points)
You may not qualify if:
- Already diagnosed with a mental disorder or had a preoperative Mini-Mental State Examination (MMSE) score of less than 27
- History of opioid abuse
- Patients who were admitted to the ICU after surgery
- Have severe cardiovascular, respiratory diseases
- Experienced critical rescue during or after the surgery
- Complicated with coagulation dysfunction, severe hypoxia or hypercapnia, or liver and kidney dysfunction
- Difficult airway management
- Changed anesthetic agent or surgical plan
- Severe lacunar cerebral infarction, ischemic stroke or other neurological diseases
- Changed anesthetic agent or surgical plan during the surgery;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, 510120, China
Biospecimen
Patient's serum
Study Officials
- STUDY DIRECTOR
Lan Lan, PHD
The First Affiliated Hospital of Guangzhou Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 13, 2026
First Posted
July 22, 2026
Study Start
July 20, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
July 22, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Access Criteria
- The data can be obtained by email from Lan Lan (Email: lanlan@gzhmu.edu.cn) for clinical requirements.
Patient clinical data